SPDR Series Trust SPDR S&P Biotech ETF (ARCA: XBI)
Ticker | Name | Share % | |
---|---|---|---|
NVAX | Novavax Inc | 3.06% | |
INSM | Insmed Inc | 2.50% | |
MRNA | Moderna Inc | 1.53% | |
NTRA | Natera Inc | 2.66% | |
DYN | Dyne Therapeutics Inc | 1.33% | |
RVMD | Revolution Medicines Inc Ser C Pc Pp | 1.32% | |
PTCT | Ptc Therapeutics Inc | 1.29% | |
BPMC | Blueprint Medicines Corp | 2.32% | |
UTHR | United Therapeutics Corp | 2.43% | |
AMGN | Amgen Inc. | 2.58% | |
GILD | Gilead Sciences Inc | 2.54% | |
ABBV | Abbvie Inc. | 2.32% | |
BMRN | Biomarin Pharmaceutical Inc. | 2.73% | |
VRTX | Vertex Pharmaceuticals Inc | 2.56% | |
INCY | Incyte Corp. | 2.33% | |
ALNY | Alnylam Pharmaceuticals Inc. | 2.68% | |
HALO | Halozyme Therapeutics Inc | 2.37% | |
BIIB | Biogen Inc. | 2.53% | |
NBIX | Neurocrine Biosciences Inc | 2.49% | |
EXAS | Exact Sciences Corp. | 2.59% |
Quote.FAQ.Answers.ETFs.etf-performance
Quote.FAQ.Answers.ETFs.expense-ratio
Quote.FAQ.Answers.ETFs.aum
XBI segue uno stile di investimento Small Cap Growth.
Le principali posizioni di XBI includono: NVAX (3.06%), INSM (2.5%), MRNA (1.53%), NTRA (2.66%), DYN (1.33%). Queste rappresentano le posizioni più grandi nel portafoglio dell'ETF.
I dati del volume medio giornaliero per XBI non sono attualmente disponibili.